Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma

P. L. Zinzani; M. Bendandi; B. Gamberi; M. Magagnoli; F. Gherlinzoni; S. Tura

Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma

P. L. Zinzani, M. Bendandi, B. Gamberi, M. Magagnoli, F. Gherlinzoni, S. Tura

Arcispedale Santa Maria Nuova

Research output: Contribution to journal › Article › peer-review

Abstract

Along with the comprehensive data concerning our institutional experience on the use of rituximab for treatment of non-Hodgkin's lymphoma, we describe the first case of molecular remission induced by the chimeric anti-CD20 monoclonal antibody in a diffuse large cell lymphoma patient.

Original language	English
Pages (from-to)	437-438
Number of pages	2
Journal	Haematologica
Volume	85
Issue number	4
Publication status	Published - 2000

Keywords

Aggressive lymphoma
Molecular remission
Rituximab

ASJC Scopus subject areas

Hematology

Cite this

@article{ae4ae920d160431cba6ab1673d3de6f0,

title = "Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma",

abstract = "Along with the comprehensive data concerning our institutional experience on the use of rituximab for treatment of non-Hodgkin's lymphoma, we describe the first case of molecular remission induced by the chimeric anti-CD20 monoclonal antibody in a diffuse large cell lymphoma patient.",

keywords = "Aggressive lymphoma, Molecular remission, Rituximab",

author = "Zinzani, {P. L.} and M. Bendandi and B. Gamberi and M. Magagnoli and F. Gherlinzoni and S. Tura",

year = "2000",

language = "English",

volume = "85",

pages = "437--438",

journal = "Haematologica",

issn = "0390-6078",

publisher = "NLM (Medline)",

number = "4",

}

TY - JOUR

T1 - Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma

AU - Zinzani, P. L.

AU - Bendandi, M.

AU - Gamberi, B.

AU - Magagnoli, M.

AU - Gherlinzoni, F.

AU - Tura, S.

PY - 2000

Y1 - 2000

N2 - Along with the comprehensive data concerning our institutional experience on the use of rituximab for treatment of non-Hodgkin's lymphoma, we describe the first case of molecular remission induced by the chimeric anti-CD20 monoclonal antibody in a diffuse large cell lymphoma patient.

AB - Along with the comprehensive data concerning our institutional experience on the use of rituximab for treatment of non-Hodgkin's lymphoma, we describe the first case of molecular remission induced by the chimeric anti-CD20 monoclonal antibody in a diffuse large cell lymphoma patient.

KW - Aggressive lymphoma

KW - Molecular remission

KW - Rituximab

UR - http://www.scopus.com/inward/record.url?scp=0034032211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034032211&partnerID=8YFLogxK

M3 - Article

C2 - 10756377

AN - SCOPUS:0034032211

VL - 85

SP - 437

EP - 438

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 4

ER -

Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this